Found: 477
Select item for more details and to access through your institution.
Evaluation of in vivo pharmacokinetic study of the anti-cancer drug imatinib using silkworms as an animal model.
- Published in:
- Drug Discoveries & Therapeutics, 2024, v. 18, n. 4, p. 245, doi. 10.5582/ddt.2024.01040
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia: Selecting First-line TKI Therapy.
- Published in:
- Journal of Clinical Outcomes Management, 2019, v. 26, n. 3, p. 131
- By:
- Publication type:
- Article
Nilotinib-induced psoriasis in a patient of chronic myeloid leukemia responding to methotrexate.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
What Is the Significance of Lysosomal-Mediated Resistance to Imatinib?
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 5, p. 709, doi. 10.3390/cells12050709
- By:
- Publication type:
- Article
Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 3, p. 571, doi. 10.3390/cells11030571
- By:
- Publication type:
- Article
Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 2, p. 344, doi. 10.3390/cells10020344
- By:
- Publication type:
- Article
Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 5, p. 506, doi. 10.3390/cells8050506
- By:
- Publication type:
- Article
Pemphigus foliaceous-like reaction in a patient with chronic myeloid leukemia treated with the tyrosine kinase inhibitors nilotinib and dasatinib.
- Published in:
- International Journal of Dermatology, 2014, v. 53, n. 4, p. 494, doi. 10.1111/j.1365-4632.2012.5728.x
- By:
- Publication type:
- Article
Histiocytoid Sweet's syndrome associated with t(9;22)(q34;q11)-positive chronic myelogenous leukemia: immature granulocytic origin of histiocytic cells.
- Published in:
- International Journal of Dermatology, 2013, v. 52, n. 12, p. 1577, doi. 10.1111/j.1365-4632.2011.05322.x
- By:
- Publication type:
- Article
Computer-aided peptide-based drug design for inositol-requiring enzyme 1.
- Published in:
- Basic & Clinical Cancer Research, 2022, v. 14, n. 4, p. 1
- By:
- Publication type:
- Article
Structural mechanism of a drug-binding process involving a large conformational change of the protein target.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36956-5
- By:
- Publication type:
- Article
Second-Generation Tyrosine Kinase Inhibitors (Tki) as Salvage Therapy for Resistant or Intolerant Patients to Prior TKIs.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2014, v. 6, n. 1, p. 1, doi. 10.4084/MJHID.2014.003
- By:
- Publication type:
- Article
Therapeutic drug monitoring of imatinib in patients of chronic myeloid leukemia – Chronic phase.
- Published in:
- Journal of Pharmacology & Pharmacotherapeutics, 2021, v. 12, n. 2, p. 61, doi. 10.4103/jpp.jpp_28_21
- By:
- Publication type:
- Article
Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cells.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2022, v. 25, n. 7, p. 904, doi. 10.22038/IJBMS.2022.64138.14121
- By:
- Publication type:
- Article
Rapamycin vs TORin-1 or Gleevec vs Nilotinib: Simple chemical evolution that converts PAK1-blockers to TOR-blockers or vice versa?
- Published in:
- Drug Discoveries & Therapeutics, 2024, v. 18, n. 2, p. 134, doi. 10.5582/ddt.2023.01097
- By:
- Publication type:
- Article
A Comprehensive Review of Chronic Myeloid Leukemia: An Indian Perspective.
- Published in:
- Journal of the Association of Genetic Technologists, 2019, v. 45, n. 4, p. 169
- By:
- Publication type:
- Article
Food‐effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burden.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 148, doi. 10.1111/ejh.13418
- By:
- Publication type:
- Article
Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 643, doi. 10.1111/ejh.13155
- By:
- Publication type:
- Article
Correction: ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells.
- Published in:
- 2018
- Publication type:
- Correction Notice
ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0192180
- By:
- Publication type:
- Article
Targeting the Proliferation Inhibition of Chronic Myeloid Leukemia Cells by Bone Marrow Derived-Mesenchymal Stem Cells via ERK Pathway as a Therapeutic Strategy.
- Published in:
- Acta Medica Iranica, 2020, v. 58, n. 5, p. 199
- By:
- Publication type:
- Article
Clinical Outcomes of CML Patients After Delayed Start of Nilotinib Treatment.
- Published in:
- UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2021, v. 31, n. 1, p. 19, doi. 10.4999/uhod.214863
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy.
- Published in:
- Molecular Diagnosis & Therapy, 2016, v. 20, n. 4, p. 315, doi. 10.1007/s40291-016-0208-1
- By:
- Publication type:
- Article
Analysis of the binding modes of the first‐ and second‐generation antiandrogens with respect to F876L mutation.
- Published in:
- Chemical Biology & Drug Design, 2021, v. 98, n. 1, p. 60, doi. 10.1111/cbdd.13848
- By:
- Publication type:
- Article
Interaction of the Efflux Transporters ABCB1 and ABCG2 With Imatinib, Nilotinib, and Dasatinib.
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 3, p. 294, doi. 10.1038/clpt.2013.208
- By:
- Publication type:
- Article
Choosing First, and Second Line Therapies in the Era of Generic TKI.
- Published in:
- Turkish Journal of Hematology, 2019, v. 36, p. 10
- By:
- Publication type:
- Article
Gonadotoxic Effects of Nilotinib in Chronic Myeloid Leukemia Treatment Dose in a Mouse Model.
- Published in:
- Turkish Journal of Hematology, 2017, v. 34, n. 2, p. 137, doi. 10.4274/tjh.2016.0092
- By:
- Publication type:
- Article
Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30.
- Published in:
- Turkish Journal of Hematology, 2017, v. 34, n. 2, p. 197, doi. 10.4274/tjh.2016.0409
- By:
- Publication type:
- Article
Occurrence of Carcinoma of the Pancreas Following Nilotinib Therapy for Chronic Myeloid Leukemia: Report of a Case with Review of the Literature.
- Published in:
- Turkish Journal of Hematology, 2015, v. 32, n. 3, p. 257, doi. 10.4274/tjh.2013.0322
- By:
- Publication type:
- Article
Exploring the Ototoxicity Associated with the Tyrosine Kinase Inhibitor Imatinib: An Experimental Study.
- Published in:
- Turkish Archives of Otolaryngology / Türk Otolarengoloji Arsivi, 2019, v. 57, p. S9, doi. 10.5152/tao.2019.20012
- By:
- Publication type:
- Article
Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63.
- Published in:
- Molecules, 2021, v. 26, n. 22, p. 6825, doi. 10.3390/molecules26226825
- By:
- Publication type:
- Article
Machine Learning Approaches to Predict Hepatotoxicity Risk in Patients Receiving Nilotinib.
- Published in:
- Molecules, 2021, v. 26, n. 11, p. 3300, doi. 10.3390/molecules26113300
- By:
- Publication type:
- Article
Nanohydroxyapatite-Mediated Imatinib Delivery for Specific Anticancer Applications.
- Published in:
- Molecules, 2020, v. 25, n. 20, p. 4602, doi. 10.3390/molecules25204602
- By:
- Publication type:
- Article
Applications and Limitations of Dendrimers in Biomedicine.
- Published in:
- Molecules, 2020, v. 25, n. 17, p. 3982, doi. 10.3390/molecules25173982
- By:
- Publication type:
- Article
Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.
- Published in:
- Molecules, 2020, v. 25, n. 7, p. 1571, doi. 10.3390/molecules25071571
- By:
- Publication type:
- Article
Structural Basis for the Regulation of PPARγ Activity by Imatinib.
- Published in:
- Molecules, 2019, v. 24, n. 19, p. 3562, doi. 10.3390/molecules24193562
- By:
- Publication type:
- Article
Development of Kinase Inhibitors via Metal-Catalyzed C-H Arylation of 8-Alkyl-thiazolo[5,4-f]-quinazolin-9-ones Designed by Fragment-Growing Studies.
- Published in:
- Molecules, 2018, v. 23, n. 9, p. 2181, doi. 10.3390/molecules23092181
- By:
- Publication type:
- Article
Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging.
- Published in:
- Molecules, 2015, v. 20, n. 12, p. 22000, doi. 10.3390/molecules201219816
- By:
- Publication type:
- Article
The Azaindole Framework in the Design of Kinase Inhibitors.
- Published in:
- Molecules, 2014, v. 19, n. 12, p. 19935, doi. 10.3390/molecules191219935
- By:
- Publication type:
- Article
Nilotinib Enhances the Efficacy of Conventional Chemotherapeutic Drugs in CD34<sup>+</sup>CD38<sup>-</sup> Stem Cells and ABC Transporter Overexpressing Leukemia Cells.
- Published in:
- Molecules, 2014, v. 19, n. 3, p. 3356, doi. 10.3390/molecules19033356
- By:
- Publication type:
- Article
Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.
- Published in:
- 2017
- By:
- Publication type:
- journal article
BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-01211-1
- By:
- Publication type:
- Article
4564 Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the cerebrospinal fluid of Parkinson's patients.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
A New Efficient Agarose Gel based Electro-membrane To Extract, Preconcentrate, Clean-up and Quantify Nilotinib in Biological Samples.
- Published in:
- Analytical & Bioanalytical Electrochemistry, 2021, v. 13, n. 3, p. 408
- By:
- Publication type:
- Article
The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitro.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, n. 4, p. 621, doi. 10.1111/bcpt.13537
- By:
- Publication type:
- Article
Nilotinib Interferes with the Signalling Pathways Implicated in Acetaminophen Hepatotoxicity.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2014, v. 114, n. 3, p. 263, doi. 10.1111/bcpt.12144
- By:
- Publication type:
- Article
Surgical resection of recurrent gastrointestinal stromal tumor after interruption of long-term nilotinib therapy.
- Published in:
- Surgical Case Reports, 2016, v. 2, n. 1, p. 1, doi. 10.1186/s40792-016-0266-y
- By:
- Publication type:
- Article
PD29 Systematic Review With Meta-analysis Of Pharmacokinetic Parameters Of Tyrosine Kinase Inhibitors Used In Chronic Myeloid Leukemia.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, p. S100, doi. 10.1017/S0266462322002896
- By:
- Publication type:
- Article
A DNA Biosensor Based on a Raspberry‐like Hierarchical Nano‐structure for the Determination of the Anticancer Drug Nilotinib.
- Published in:
- ChemistryOpen, 2022, v. 11, n. 3, p. 1, doi. 10.1002/open.202100261
- By:
- Publication type:
- Article
Nilotinib induction of melanogenesis via reactive oxygen species‐dependent JNK activation in B16F0 mouse melanoma cells.
- Published in:
- Experimental Dermatology, 2018, v. 27, n. 12, p. 1388, doi. 10.1111/exd.13797
- By:
- Publication type:
- Article